Medikament- und Pharmaforschung in Ihrer Nähe. Weitere Infos finden Sie hier! Forschung, Innovationen und Arbeitsplätze- Made in Germany. Hier finden Sie uns!
An altogether different CDMO with over 40 years of experience. Developer and manufacturer of drug substances and drug products.
Suchergebnisse
Suchergebnisse:
INFIQ | Infinity Pharmaceuticals Aktien News ☑ Mit Realtime Kurs, Dividende und Prognose der Infinity Pharmaceuticals Aktie Analysiere mit wallstreetONLINE.
INFINITY PHARMACEUTICALS AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie Infinity Pharmaceuticals IncShs | A0LA4Y | INFIQ | US45665G3039
Infinity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel medicines for people with cancer. The company's product candidate, including eganelisib (IPI ...
24. Juli 2023 · Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) is a clinical-stage biotechnology company developing eganelisib (IPI-549), a potential first-in-class, oral, immuno-oncology macrophage...
14. Juli 2023 · Infinity Pharmaceuticals, a biotech company developing eganelisib, a macrophage reprogramming drug candidate, announced that its stockholders have approved the merger agreement with MEI Pharma, a biopharmaceutical company. The merger is subject to approval by MEI stockholders and is expected to create a combined company with enhanced clinical and commercial capabilities.
Infinity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel medicines for people with cancer. The company's product candidate, including eganelisib (IPI-549), an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in ...
Realtime Aktienkurs der INFINITY PHARMACEUTICALS Aktie mit Live-Chart inkl. Kursentwicklung, News & Analysen. Aktueller Aktienwert heute inkl. Aktienverlauf & Wertentwicklung.